Role of folic Acid on symptoms of chronic arsenic toxicity

Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory. Methylation of arsenic facilitates its urinary excretion. Persons with relatively lower proportion of urinary dimethyl arsenic acid (DMA) are fou...

Full description

Saved in:
Bibliographic Details
Published in:International journal of preventive medicine Vol. 5; no. 1; pp. 89 - 98
Main Authors: Ghose, Nelima, Majumdar, Kunal Kanti, Ghose, A K, Saha, C K, Nandy, A K, Mazumder, D N Guha
Format: Journal Article
Language:English
Published: Iran Medknow Publications & Media Pvt Ltd 01-01-2014
Wolters Kluwer Medknow Publications
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory. Methylation of arsenic facilitates its urinary excretion. Persons with relatively lower proportion of urinary dimethyl arsenic acid (DMA) are found to have at greater risk of developing symptoms of arsenicosis including its complications. The biochemical pathway responsible for methylation of arsenic is a folate-dependent pathway. Studies in rodents and humans suggest that folate nutritional status influences the metabolism of arsenic. The present study compares the effect of giving folic acid on 32 arsenicosis patients during a 6-month period and comparing the results with clinical effect of taking only arsenic-free safe water on 45 age and sex-matched arsenic-affected people for the same period. There was significant improvement of arsenical skin lesion score of both patients treated with folic acid (2.96 ± 1.46 to 1.90 ± 0.90, P < 0.001) and arsenic free safe water (2.91 ± 1.26 to 1.62 ± 1.05, P < 0.001) for a period of 6 months. Significant improvement in systemic disease score was also observed from the baseline systemic score in folic acid treated group (4.78 ± 3.43 to 1.00 ± 1.56, P < 0.001) and the group treated with arsenic-free water (1.87 ± 2.11 to 0.82 ± 1.62, P < 0.001). However, there was a significant increased improvement of systematic disease score in the folic acid treated group compared to the control group taking arsenic free water (P < 0.001). This study provides evidence that folic acid treatment in arsenicosis cases could help in reducing clinical symptoms of arsenicosis.
AbstractList BACKGROUNDChronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory. Methylation of arsenic facilitates its urinary excretion. Persons with relatively lower proportion of urinary dimethyl arsenic acid (DMA) are found to have at greater risk of developing symptoms of arsenicosis including its complications. The biochemical pathway responsible for methylation of arsenic is a folate-dependent pathway. Studies in rodents and humans suggest that folate nutritional status influences the metabolism of arsenic. METHODSThe present study compares the effect of giving folic acid on 32 arsenicosis patients during a 6-month period and comparing the results with clinical effect of taking only arsenic-free safe water on 45 age and sex-matched arsenic-affected people for the same period. RESULTSThere was significant improvement of arsenical skin lesion score of both patients treated with folic acid (2.96 ± 1.46 to 1.90 ± 0.90, P < 0.001) and arsenic free safe water (2.91 ± 1.26 to 1.62 ± 1.05, P < 0.001) for a period of 6 months. Significant improvement in systemic disease score was also observed from the baseline systemic score in folic acid treated group (4.78 ± 3.43 to 1.00 ± 1.56, P < 0.001) and the group treated with arsenic-free water (1.87 ± 2.11 to 0.82 ± 1.62, P < 0.001). However, there was a significant increased improvement of systematic disease score in the folic acid treated group compared to the control group taking arsenic free water (P < 0.001). CONCLUSIONSThis study provides evidence that folic acid treatment in arsenicosis cases could help in reducing clinical symptoms of arsenicosis.
Background: Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory. Methylation of arsenic facilitates its urinary excretion. Persons with relatively lower proportion of urinary dimethyl arsenic acid (DMA) are found to have at greater risk of developing symptoms of arsenicosis including its complications. The biochemical pathway responsible for methylation of arsenic is a folate-dependent pathway. Studies in rodents and humans suggest that folate nutritional status influences the metabolism of arsenic. Methods: The present study compares the effect of giving folic acid on 32 arsenicosis patients during a 6-month period and comparing the results with clinical effect of taking only arsenic-free safe water on 45 age and sex-matched arsenic-affected people for the same period. Results: There was significant improvement of arsenical skin lesion score of both patients treated with folic acid (2.96 ± 1.46 to 1.90 ± 0.90, P < 0.001) and arsenic free safe water (2.91 ± 1.26 to 1.62 ± 1.05, P < 0.001) for a period of 6 months. Significant improvement in systemic disease score was also observed from the baseline systemic score in folic acid treated group (4.78 ± 3.43 to 1.00 ± 1.56, P < 0.001) and the group treated with arsenic-free water (1.87 ± 2.11 to 0.82 ± 1.62, P < 0.001).However, there was a significant increased improvement of systematic disease score in the folic acid treated group compared to the control group taking arsenic free water ( P < 0.001). Conclusions: This study provides evidence that folic acid treatment in arsenicosis cases could help in reducing clinical symptoms of arsenicosis.
Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory. Methylation of arsenic facilitates its urinary excretion. Persons with relatively lower proportion of urinary dimethyl arsenic acid (DMA) are found to have at greater risk of developing symptoms of arsenicosis including its complications. The biochemical pathway responsible for methylation of arsenic is a folate-dependent pathway. Studies in rodents and humans suggest that folate nutritional status influences the metabolism of arsenic. The present study compares the effect of giving folic acid on 32 arsenicosis patients during a 6-month period and comparing the results with clinical effect of taking only arsenic-free safe water on 45 age and sex-matched arsenic-affected people for the same period. There was significant improvement of arsenical skin lesion score of both patients treated with folic acid (2.96 ± 1.46 to 1.90 ± 0.90, P < 0.001) and arsenic free safe water (2.91 ± 1.26 to 1.62 ± 1.05, P < 0.001) for a period of 6 months. Significant improvement in systemic disease score was also observed from the baseline systemic score in folic acid treated group (4.78 ± 3.43 to 1.00 ± 1.56, P < 0.001) and the group treated with arsenic-free water (1.87 ± 2.11 to 0.82 ± 1.62, P < 0.001). However, there was a significant increased improvement of systematic disease score in the folic acid treated group compared to the control group taking arsenic free water (P < 0.001). This study provides evidence that folic acid treatment in arsenicosis cases could help in reducing clinical symptoms of arsenicosis.
Author Majumdar, Kunal Kanti
Saha, C K
Mazumder, D N Guha
Ghose, Nelima
Nandy, A K
Ghose, A K
AuthorAffiliation 2 Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India
1 Department of Community Medicine, KPC Medical College and Hospital, Jadavpur, Kolkata, India
DNGM Research Foundation, Kolkata, India
3 Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India
AuthorAffiliation_xml – name: DNGM Research Foundation, Kolkata, India
– name: 2 Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India
– name: 3 Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India
– name: 1 Department of Community Medicine, KPC Medical College and Hospital, Jadavpur, Kolkata, India
Author_xml – sequence: 1
  givenname: Nelima
  surname: Ghose
  fullname: Ghose, Nelima
  organization: DNGM Research Foundation, Kolkata, India
– sequence: 2
  givenname: Kunal Kanti
  surname: Majumdar
  fullname: Majumdar, Kunal Kanti
  organization: Department of Community Medicine, KPC Medical College and Hospital, Jadavpur, Kolkata, India
– sequence: 3
  givenname: A K
  surname: Ghose
  fullname: Ghose, A K
  organization: DNGM Research Foundation, Kolkata, India
– sequence: 4
  givenname: C K
  surname: Saha
  fullname: Saha, C K
  organization: Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India
– sequence: 5
  givenname: A K
  surname: Nandy
  fullname: Nandy, A K
  organization: Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, India
– sequence: 6
  givenname: D N Guha
  surname: Mazumder
  fullname: Mazumder, D N Guha
  organization: DNGM Research Foundation, Kolkata, India
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24554997$$D View this record in MEDLINE/PubMed
BookMark eNpVkFtLAzEQhYNUbK39C7KPvhRy3U18EErxUhAE0eeQTWbblN1N3WzF_ntTW8VmHs4wZ-Y7kEs0aEMLZ2hEMZZTSQkbHPtCYjpEkxjXOD2m8pyKCzSkXAiuVDFCt6-hhixUWRVqb7OZ9S4LbRZ3zaYPTdw7dtWFNnmmi7DXPnx56_vdFTqvTB1hctQxen-4f5s_TZ9fHhfz2fPUMUb7acVymsoorDgT1AGWtjQcO0GIFYxIDoSAkkzmsiDMMFcZ4IRj5UogwNgYLQ5cF8xabzrfmG6ng_H6ZxC6pTZd720N2hpl0lHuaEm4TZmlKHIsSVJgBkxi3R1Ym23ZgLPQ9p2pT6CnTutXehk-NVNE8EIlwM0R0IWPLcReNz5aqGvTQthGTQQmrOBEFGn1-n_WX8jv57NvRK6DYg
ContentType Journal Article
Copyright Copyright: © International Journal of Preventive Medicine 2014
Copyright_xml – notice: Copyright: © International Journal of Preventive Medicine 2014
DBID NPM
7X8
5PM
DOA
DatabaseName PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 2008-8213
EndPage 98
ExternalDocumentID oai_doaj_org_article_ca9abe16d2b14c6a9b5760819b5e3aea
24554997
Genre Journal Article
GroupedDBID ---
3V.
53G
5VS
7X7
7XC
8FE
8FH
8FI
8FJ
8G5
AAKDD
ABDBF
ABUWG
ABXLX
ACGFS
ADBBV
ADRAZ
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CWDGH
DIK
DWQXO
EBD
EOJEC
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HMCUK
HYE
IAO
IEA
IHR
IHW
IPNFZ
ITC
KQ8
KWQ
M2O
M48
M~E
NPM
O5R
O5S
OBODZ
OK1
OVD
P2P
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RMW
RNS
RPM
TEORI
TUS
UKHRP
W3E
7X8
5PM
ID FETCH-LOGICAL-d332t-f362626a9094352de08cba40d511c53184e11e983868713a3dfae41409dbe1e33
IEDL.DBID RPM
ISSN 2008-7802
IngestDate Tue Oct 22 15:08:49 EDT 2024
Tue Sep 17 20:35:51 EDT 2024
Sat Aug 17 03:56:20 EDT 2024
Sat Sep 28 08:01:56 EDT 2024
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Arsenicosis
treatment of arsenicosis
nutritional deficiency
folic acid
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-d332t-f362626a9094352de08cba40d511c53184e11e983868713a3dfae41409dbe1e33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915479/
PMID 24554997
PQID 1501374157
PQPubID 23479
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_ca9abe16d2b14c6a9b5760819b5e3aea
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3915479
proquest_miscellaneous_1501374157
pubmed_primary_24554997
PublicationCentury 2000
PublicationDate 2014-Jan
20140101
2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-Jan
PublicationDecade 2010
PublicationPlace Iran
PublicationPlace_xml – name: Iran
– name: India
PublicationTitle International journal of preventive medicine
PublicationTitleAlternate Int J Prev Med
PublicationYear 2014
Publisher Medknow Publications & Media Pvt Ltd
Wolters Kluwer Medknow Publications
Publisher_xml – name: Medknow Publications & Media Pvt Ltd
– name: Wolters Kluwer Medknow Publications
References 6894292 - Int Arch Occup Environ Health. 1981;48(1):71-9
10536752 - Drug Chem Toxicol. 1999 Nov;22(4):613-28
15238285 - Environ Health Perspect. 2004 Jul;112(10):1104-9
18709164 - Environ Health Perspect. 2008 Aug;116(8):1056-62
15694460 - Toxicol Appl Pharmacol. 2005 Feb 15;203(1):18-26
11778664 - J Toxicol Clin Toxicol. 2001;39(7):665-74
15941889 - Am J Clin Nutr. 2005 Jun;81(6):1372-7
3590229 - Toxicol Lett. 1987 Jun;37(1):41-6
20922118 - Indian J Community Med. 2010 Apr;35(2):331-8
14581169 - Toxicol Lett. 2003 Nov 30;145(2):167-74
9219569 - Mutat Res. 1997 Jun;386(3):315-34
11484904 - Pharmacol Toxicol. 2001 Jul;89(1):1-5
12635824 - J Environ Sci Health A Tox Hazard Subst Environ Eng. 2003 Jan;38(1):141-63
17093162 - Am J Clin Nutr. 2006 Nov;84(5):1093-101
10884384 - J Biol Chem. 2000 Sep 22;275(38):29318-23
12846360 - Cancer Causes Control. 2003 May;14(4):303-10
8793350 - Environ Health Perspect. 1996 Jun;104(6):620-8
9865236 - J Toxicol Clin Toxicol. 1998;36(7):683-90
16039941 - Toxicol Appl Pharmacol. 2005 Aug 15;206(3):299-308
11097236 - Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1259-62
10397578 - Int J Dermatol. 1999 Jun;38(6):401-10
16330347 - Environ Health Perspect. 2005 Dec;113(12):1683-8
12176088 - Food Chem Toxicol. 2002 Nov;40(11):1611-21
12661181 - J Occup Environ Med. 2003 Mar;45(3):241-8
9264271 - Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):589-96
References_xml
SSID ssj0000396625
Score 2.056211
Snippet Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is unsatisfactory....
BACKGROUNDChronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is...
Background: Chronic arsenic toxicity (Arsenicosis) due to drinking of arsenic contaminated ground water is a global problem. However, its treatment is...
SourceID doaj
pubmedcentral
proquest
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 89
SubjectTerms Arsenicosis
folic acid
nutritional deficiency
Original
treatment of arsenicosis
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA66J0HEt-uLCF6LbZK2qTcfu3jy4AO8lTSZ4oLbLrYL-u-dadZlVwQvngqdQ6czaeebyeQbxs51LGIpIhdEVrlAORUHBqNUECLWsDpM01B0Q2wf0_sXfTsgmpz5qC_qCfP0wN5wF9ZkpoAocaKIlE1MViBCpjhWxCANeGgUJgvJVPcPlgjju4mr3f5-qqls0pHy_4YkfzZELkSY4SbbmEFDfuVV2mIrUG2zdV9X4_640A67fKjfgNclL4nQlxs7cryuePM5nrT1uCGJ9Xy3HFNWoGtbf4wsgu1d9jwcPN3cBbP5B4GTUrRBSVQxAl-Zuv9i4SDUtjAqdAiSLH47WkEUQaalTjDtkUa60oAiBiuHFgMp91ivqis4YFwlxpUxjT9wQoGl07CqUCYrAQQNQ--zazJOPvEUFzmRTnc30BX5zBX5X67os7Nv0-a4SGnnwVRQT5scUWckCbukfbbvTT1_lFAx5agoSZecsKTLsqQavXZE2ERur9Ls8D-UP2JriIWUr64cs177PoUTttq46Wm3tL4AP4vVVw
  priority: 102
  providerName: Directory of Open Access Journals
Title Role of folic Acid on symptoms of chronic arsenic toxicity
URI https://www.ncbi.nlm.nih.gov/pubmed/24554997
https://search.proquest.com/docview/1501374157
https://pubmed.ncbi.nlm.nih.gov/PMC3915479
https://doaj.org/article/ca9abe16d2b14c6a9b5760819b5e3aea
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB5sT4KIb-uLCF7TJrubJvFWa4sXRWwFb2GzO9FCm5Q-QP-9O5tUWvHkKZAlm2Fmkv1md-YbgJsoYAFnvnZ9JbQrtAhcaVYp1zNYQ0VeGHrMNrEdhE9v0X2PaHKCVS2MTdpX6aiZjyfNfPRhcyunE9Va5Ym1nh-7RGouwrhVg5rBhmshuv39coPgbbNVe7QfRh51rGEioEgorKj5_8KTv9Mi19aZ_h7sVgDR6ZSC7MMW5gewU-6uOWXR0CHcvhRjdIrM6ROtr9NRI-0UuTP4mkwXxWROIxXrrZlojnQdFp8jZSD3Ebz2e8Pug1t1QXA152zhZkQYw9oyphzAgGn0IpVK4WkDlZT5giKBvo9xxKO2CX645DqTKIjHSqfoI-fHUM-LHE_BEW2ps4CaIGgmUFFNrEiFjDNERi3RG3BHykmmJdFFQtTT9kYxe08qAyRKxtJM3NYs9YUycqUmZCFgkQbIJcoGXK9UmxhXpfMHmWOxnCcGe_qcEEzYgJNS1T-vWtmnAeGGETZk2Rwx3mHpsCtvOPv3k-ewbWCQKDdWLqC-mC3xEmpzvbyyIfqVdbBvxxjU_Q
link.rule.ids 230,315,729,782,786,887,2106,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZ4HEBCvB_jWSSuZW2Sri23MZhAPIRgSNyqNHFh0tZObJPg3xOnHWKIE6dKtZJacdJ8TuzPACdRwALOfO36SmhXaBG40uxSrmewhoq8MPSYLWL7FN6_RBeXRJMTTHJhbNC-Srunea9_mnffbGzloK_qkzix-sNdi0jNRRjXZ2HerFfP--Gk2x8wNxjellu1l_th5FHNGiYC8oXCipz_L0T5OzDyx07TXvmnjquwXEFLp1mK12AG83VYKs_lnDLdaAPOHoseOkXmtIkQ2GmqrnaK3Hn67A9GRX9Ikoov13Q0RHp2io-uMmB9E57bl53WlVvVT3A152zkZkQ1wxoypujBgGn0IpVK4WkDspRZe5FA38c44lHDuE1ccp1JFMSApVP0kfMtmMuLHHfAEQ2ps4DKJ2gmUFE2rUiFjDNERsXUa3BOg5oMSoqMhEir7Yvi_TWphiVRMpam44ZmqS-U0Ss1zg5BkjRALlHW4HhiksRMcrq5kDkW42FiUKvPCfuENdguTfT9qYldaxBOGW9Kl2mJsZkl0q5stPvvlkewcNW5u01ur-9v9mDRgClRHs_sw9zofYwHMDvU40M7Pb8A0Nvplg
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fT9swED4NJk1ICDZ-jALbgsRraGI7TcJbKVSbBggNkHiLHPvCKrVJRVuJ_fe7c1JEEU_wFCn-EcufHX9nn78DOEwiEUkRWj80yvrKqsjXtEr5AXENkwRxHAgXxPY6vrxLTs9YJucp1Jdz2jf54Kgcjo7KwV_nWzkemfbcT6x9ddFjUXMVp-2xLdpL8JHmbCCeGeruJyyJx7uQq-6AP6YcrPurIraH4kag_zVW-dI58tlq019_Rzs_w1pDMb1uneULfMByA1br_Tmvvna0Ccd_qiF6VeH1WRjY65qB9arSu_43Gk-r0YRTGt1cqmiC_LypHgeGSPsW3PbPbno__SaOgm-lFFO_YMkZ0dEpexFGwmKQmFyrwBLZMjQHE4VhiGkikw6ZT1JLW2hUrIRlcwxRym1YLqsSd8BTHW2LiMMoWKHQ8K1alSudFoiCg6q34IQ7NhvXUhkZi1e7F9XDfdZ0TWZ0qqnijhV5qAy1Kyejh6lJHqHUqFtwMIclo8HOJxi6xGo2yYi9hpI5UNyCrzVMT5-aY9uCeAHAhbYsphBuTlC7wWn3zSV_wKer0352_uvy9x6sEKdS9S7NPixPH2b4DZYmdvbdjdD_PevsFg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+folic+Acid+on+symptoms+of+chronic+arsenic+toxicity&rft.jtitle=International+journal+of+preventive+medicine&rft.au=Ghose%2C+Nelima&rft.au=Majumdar%2C+Kunal+Kanti&rft.au=Ghose%2C+A+K&rft.au=Saha%2C+C+K&rft.date=2014-01-01&rft.issn=2008-7802&rft.volume=5&rft.issue=1&rft.spage=89&rft.epage=98&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2008-7802&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2008-7802&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2008-7802&client=summon